SBK-002

To evaluate the safety, tolerability, and pharmacokinetic/pharmacodynamic characteristics of SBK002 tablets after a single dose in healthy adult Chinese subjects.

1) To analyze the excretion pathway of [14C]sbk002 after oral administration to subjects; 2) To identify the main metabolites of [14C]sbk002 in the human body after oral administration to subjects; 3) To investigate the pharmacokinetics of total radioactivity after oral administration of [14C]sbk002 to subjects.